{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:00:42Z","timestamp":1793016042665,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac amyloidosis is an underrecognized etiology of heart failure with preserved ejection fraction (HFpEF), particularly in elderly patients. Light-chain (AL) amyloidosis, when associated with multiple myeloma, is highly aggressive and portends a poor prognosis, especially in advanced cardiac stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a 79-year-old male with type 2 diabetes, hypertension, and a history of pacemaker implantation for complete atrioventricular block in the context of atrial fibrillation. He was admitted with progressive exertional dyspnea and an episode of syncope. Clinical examination revealed fine basal crackles and signs of decompensated heart failure. ECG demonstrated a paced rhythm. Echocardiography and cardiac MRI revealed concentric left ventricular hypertrophy with a sparkling myocardial texture, biatrial dilation, restrictive filling pattern, and diffuse subendocardial late gadolinium enhancement\u2014features highly suggestive of cardiac amyloidosis. Laboratory tests revealed anemia, nephrotic syndrome, elevated troponin and NT-proBNP, and a monoclonal IgG lambda spike. Renal biopsy demonstrated amyloid deposits with Congo red positivity and light-chain (lambda) restriction, confirming the diagnosis of AL amyloidosis. Bone marrow biopsy confirmed the diagnosis of multiple myeloma with plasma cell infiltration. Based on clinical and laboratory findings, the patient was classified as Mayo stage IIIB AL cardiac amyloidosis and ISS stage I multiple myeloma. He received bortezomib-cyclophosphamide-based chemotherapy and supportive care, but unfortunately died five months after diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case highlights the importance of early recognition of cardiac amyloidosis in elderly patients with unexplained heart failure and monoclonal gammopathy. Echocardiography plays a pivotal role in early disease suspicion, particularly in resource-limited settings, while cardiac MRI serves as a complementary tool for assessing myocardial involvement. Despite advances in treatment, outcomes remain poor in advanced cardiac involvement. Early intervention may improve prognosis, underscoring the need for heightened clinical awareness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Infiltrative cardiomyopathies like AL amyloidosis should be considered in elderly patients with heart failure and systemic red flags. Timely diagnosis and multidisciplinary management are essential but often insufficient in advanced stages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-026-00715-w","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:34:21Z","timestamp":1767699261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Silent progression: cardiac amyloidosis unmasking IgG lambda myeloma in an elderly patient"],"prefix":"10.1186","volume":"78","author":[{"given":"Soufiane","family":"Touiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Bouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"El Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliyasse","family":"Asfalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouhair","family":"Lakhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatif","family":"Benyass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"715_CR1","doi-asserted-by":"crossref","unstructured":"Muchtar E, Dispenzieri A, Magen H et al (2021) Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. ;289(3):268\u2013292.","DOI":"10.1111\/joim.13169"},{"key":"715_CR2","unstructured":"Kyle RA, Gertz MA (1995) Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 32(1):45\u201359."},{"key":"715_CR3","doi-asserted-by":"publisher","unstructured":"Tana M, Piccinini R, Moffa L, Tana C (2024) Heart failure with preserved ejection fraction and cardiac amyloidosis in the aging heart. Int J Mol Sci. 25(21):11519.https:\/\/doi.org\/10.3390\/ijms252111519","DOI":"10.3390\/ijms252111519"},{"key":"715_CR4","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1002\/ajh.25685","volume":"95","author":"A Staron","year":"2020","unstructured":"Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V (2020) Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: a zebra without stripes. Am J Hematol . 95:E45\u2013E48. https:\/\/doi.org\/10.1002\/ajh.25685","journal-title":"Am J Hematol"},{"key":"715_CR5","doi-asserted-by":"crossref","unstructured":"Huan T, Nguyen, Chuyen TH, Nguyen (2020) Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review, Eur Heart J Case Rep. 4(6): 1-7","DOI":"10.1093\/ehjcr\/ytaa325"},{"key":"715_CR6","doi-asserted-by":"crossref","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 42:1554-68.","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"715_CR7","doi-asserted-by":"crossref","unstructured":"Gertz MA, Comenzo R, Falk RH et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol. 79(4):319\u2013328.","DOI":"10.1002\/ajh.20381"},{"key":"715_CR8","doi-asserted-by":"crossref","unstructured":"Donnelly JP, Hanna M (2017) Cardiac amyloidosis: an update on diagnosis and treatment. Cleve Clin J Med. 84(12 Suppl 3):12\u201326.","DOI":"10.3949\/ccjm.84.s3.02"},{"key":"715_CR9","doi-asserted-by":"crossref","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 132(16):1570\u20131579.","DOI":"10.1161\/CIRCULATIONAHA.115.016567"},{"key":"715_CR10","doi-asserted-by":"publisher","unstructured":"Razvi Y, Patel RK, Fontana M, Gillmore JD (2021) Cardiac amyloidosis: a review of current imaging techniques. Front Cardiovasc Med. 8:751293.https:\/\/doi.org\/10.3389\/fcvm.2021.751293. 2021","DOI":"10.3389\/fcvm.2021.751293"},{"key":"715_CR11","doi-asserted-by":"crossref","unstructured":"Kumar S, Dispenzieri A, Lacy MQ et al (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol.30(9):989\u2013995.","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"715_CR12","unstructured":"Palladini G, Merlini G (2020) Multiple myeloma and AL amyloidosis: similarities and differences. Haematologica.105(3):562\u2013564."},{"key":"715_CR13","doi-asserted-by":"publisher","unstructured":"R\u00edos-Tamayo R, Krsnik I, G\u00f3mez-Bueno M, Garcia-Pavia P, Segovia-Cubero J, Huerta A, Salas C, Silvestre R\u00c1, S\u00e1nchez A, Manso M, Delgado L, Lahuerta JJ, Mart\u00ednez-L\u00f3pez J, Duarte RF (2023) AL Amyloidosis and multiple myeloma: a complex scenario in which cardiac involvement remains the key prognostic factor. Life. 13(7):1518. https:\/\/doi.org\/10.3390\/life13071518. PMID: 37511893; PMCID: PMC10382070. 2023","DOI":"10.3390\/life13071518"},{"key":"715_CR14","doi-asserted-by":"publisher","unstructured":"Xu J, Wang M, Shen Y et al (2021) Effects of amyloid light-chain amyloidosis on clinical characteristics and prognosis in multiple myeloma: a single-center retrospective study. Cancer Manag Res. 13:1343\u20131356.https:\/\/doi.org\/10.2147\/CMAR.S287922. 2021","DOI":"10.2147\/CMAR.S287922"},{"key":"715_CR15","doi-asserted-by":"publisher","unstructured":"Pour-Ghaz I, Bath A, Kayali S et al (2022) A review of cardiac amyloidosis: presentation, diagnosis, and treatment. Curr Probl Cardiol. 47(12):101366. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101366. 2022","DOI":"10.1016\/j.cpcardiol.2022.101366"},{"key":"715_CR16","doi-asserted-by":"crossref","unstructured":"Kastritis E, Palladini G, Minnema MC et al (2021) Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med. 385(1):46\u201358.","DOI":"10.1056\/NEJMoa2028631"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-026-00715-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:34:23Z","timestamp":1767699263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43044-026-00715-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1186\/s43044-026-00715-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6498469\/v1","asserted-by":"object"}]},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}